Work

The anti-IL-33 antibody, itepekimab, potently blocks airway inflammation post a single dose in mice

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa885

Authors: Seblewongel Asrat, Randi Foster, George Scott, Dylan Birchard, Li-Hong Ben, Jeanne Allinne, Andrew Murphy, Pamela Krueger, Matthew Sleeman, Jamie Orengo

Institution: Regeneron (United States)

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404100970

Cites:

Cited by: 1

Related to: 10